Hostname: page-component-7b7567c8c-jvr6b Total loading time: 0 Render date: 2026-11-15T23:30:53.760Z Has data issue: false hasContentIssue false

Predictive role of blood eosinophils in adult varicella patients

Published online by Cambridge University Press:  21 June 2022

Luxuan Yang*
Affiliation:
Department of Infection Disease, The Fifth People's Hospital of Suzhou, Suzhou, Jiangsu, China
Wenyong Zhang
Affiliation:
Department of Infection Disease, The Fifth People's Hospital of Suzhou, Suzhou, Jiangsu, China
Xiujuan Shen
Affiliation:
Department of Infection Disease, The Fifth People's Hospital of Suzhou, Suzhou, Jiangsu, China
Jianguo Chang
Affiliation:
Department of Infection Disease, The Fifth People's Hospital of Suzhou, Suzhou, Jiangsu, China
Meiqin Liu
Affiliation:
Department of Infection Disease, The Fifth People's Hospital of Suzhou, Suzhou, Jiangsu, China
*
Author for correspondence: Luxuan Yang, E-mail: 596775823@qq.com
Rights & Permissions [Opens in a new window]

Abstract

The study aimed to explore the relationship between eosinophils and the prognosis of varicella in adults. We retrospectively reviewed the medical records of patients who were hospitalised in The Fifth People's Hospital of Suzhou with a diagnosis of adult varicella during the period between 1 January 2012 and 31 December 2020. Of the 359 patients, 228 (63.51%) had eosinopenia. The proportion of patients with mild type disease was significantly lower in the eosinopenia group than that in the non-eosinopenia group (50.44% vs. 65.65%, P = 0.006). The proportion of the patients with common type disease was significantly higher in the eosinopenia group than that in the non-eosinopenia group (39.47% vs. 28.24%, P = 0.039). The proportion of the patients with severe type disease was higher in the eosinopenia group, although the difference did not reach statistical significance (10.09% vs. 6.11%, P = 0.243). The rates of high fever (47.81% vs. 32.82%, P = 0.008; relative risk (RR) 1.296, 95% confidence interval (CI) 1.091–1.540), headache (43.42% vs. 22.14%, P < 0.001; RR 1.415, 95% CI 1.233–1.623), anorexia (53.51% vs. 35.88%, P = 0.001; RR 1.367, 95% CI 1.129–1.655) and complications (82.89% vs. 64.12%, P < 0.001; RR 2.106, 95% CI 1.460–3.038) were also significantly higher in the eosinopenia group. Among the complications, the liver injury and skin infection were more serious in the eosinopenia group. The disease course was significantly longer in the eosinopenia group than that in the non-eosinopenia group (9.43 ± 1.89 days vs. 8.73 ± 1.25 days, P < 0.001). The improvement rate of liver injury in the recovery period was lower in the eosinopenia group than that in the non-eosinopenia group (35.38% vs. 50%, P = 0.012). The study found that adult varicella patients with eosinopenia had a more serious condition, a higher morbidity of complications and a slower recovery. Blood eosinophils can be used as a new predictor of the severity of adult varicella.

Information

Type
Original Paper
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
Copyright
Copyright © The Author(s), 2022. Published by Cambridge University Press
Figure 0

Table 1.General conditions of adult varicella patients

Figure 1

Table 2.Severity between the eosinopenia group and the non-eosinopenia group

Figure 2

Table 3.Sex, age, uncomfortable symptoms and complications between the eosinopenia group and the non-eosinopenia group

Figure 3

Table 4.Associations between eosinopenia and high fever, headache, anorexia, complications

Figure 4

Table 5.Liver damage and skin infection between the eosinopenia group and the non-eosinopenia group

Figure 5

Table 6.Prognosis between the eosinopenia group and the non-eosinopenia group

Figure 6

Table 7.Infection indexes and lymphocyte subsets between the eosinopenia group and the non-eosinopenia group